MZF1 and breast neoplasm: This process involves the poly-SUMOylation of myeloid zinc finger-1 (MZF1) at K23 directs MZF1 phosphorylation at S27 to further mediate invasive ERBB2 signaling in breast tumors (Fig. 1C) [97].